Trials / Completed
CompletedNCT00590759
Evaluation of the GORE TAG Thoracic Endoprosthesis in the Treatment of Aneurysms
A Clinical Evaluation of the GORE TAG Thoracic Endoprosthesis in the Primary Treatment of Descending Thoracic Aortic Aneurysms
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-approval study is to evaluate the long-term performance of the GORE TAG® Thoracic Endoprosthesis (TAG device) in the primary treatment of descending thoracic aortic (DTA) aneurysms
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE TAG® Thoracic Endoprosthesis | implant |
Timeline
- Start date
- 2005-08-01
- Primary completion
- 2013-04-01
- Completion
- 2013-04-01
- First posted
- 2008-01-11
- Last updated
- 2014-08-07
- Results posted
- 2014-08-07
Locations
25 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00590759. Inclusion in this directory is not an endorsement.